TuHURA Biosciences, Inc. (HURA)
2.05
-0.08
(-3.76%)
USD |
NASDAQ |
Sep 23, 16:00
2.05
0.00 (0.00%)
Pre-Market: 08:24
TuHURA Biosciences Market Cap : 130.55M for Sept. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 23, 2026 | 130.55M |
| September 22, 2026 | 135.64M |
| September 21, 2026 | 138.83M |
| September 18, 2026 | 133.73M |
| September 17, 2026 | 133.10M |
| September 16, 2026 | 129.28M |
| September 15, 2026 | 129.28M |
| September 14, 2026 | 130.55M |
| September 11, 2026 | 130.55M |
| September 10, 2026 | 129.28M |
| September 09, 2026 | 128.00M |
| September 08, 2026 | 135.01M |
| September 04, 2026 | 136.28M |
| September 03, 2026 | 133.73M |
| September 02, 2026 | 133.10M |
| September 01, 2026 | 129.28M |
| August 31, 2026 | 135.64M |
| August 28, 2026 | 134.37M |
| August 27, 2026 | 135.64M |
| August 26, 2026 | 135.64M |
| August 25, 2026 | 129.91M |
| August 24, 2026 | 136.92M |
| August 21, 2026 | 127.36M |
| August 20, 2026 | 141.38M |
| August 19, 2026 | 145.20M |
| Date | Value |
|---|---|
| August 18, 2026 | 137.55M |
| August 17, 2026 | 145.20M |
| August 14, 2026 | 157.30M |
| August 13, 2026 | 146.47M |
| August 12, 2026 | 149.02M |
| August 11, 2026 | 146.47M |
| August 10, 2026 | 136.69M |
| August 07, 2026 | 135.42M |
| August 06, 2026 | 134.47M |
| August 05, 2026 | 132.88M |
| August 04, 2026 | 132.88M |
| August 03, 2026 | 136.06M |
| July 31, 2026 | 137.97M |
| July 30, 2026 | 137.97M |
| July 29, 2026 | 129.70M |
| July 28, 2026 | 135.42M |
| July 27, 2026 | 140.51M |
| July 24, 2026 | 134.15M |
| July 23, 2026 | 136.69M |
| July 22, 2026 | 142.42M |
| July 21, 2026 | 140.51M |
| July 20, 2026 | 142.42M |
| July 17, 2026 | 143.05M |
| July 16, 2026 | 141.14M |
| July 15, 2026 | 144.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.377B |
| Alnylam Pharmaceuticals, Inc. | 32.97B |
| Anika Therapeutics, Inc. | 272.68M |
| Savara, Inc. | 1.027B |
| Vericel Corp. | 1.985B |
Market Cap Related Metrics
| Price to Book Value | 7.164 |
| Price | 2.05 |
| Earnings Yield | -26.01% |